Results 261 to 270 of about 1,191,145 (307)
Some of the next articles are maybe not open access.

Expression of the carcinoma-associated antigens CA 19-9 and CA-50 in inflammatory bowel disease

Diseases of the Colon & Rectum, 1987
The expression of gastrointestinal cancer antigen, CA 19-9, and of carcinoma-associated antigen, CA-50, was studied in formalin-fixed and paraffin-embedded tissue from 18 patients with ulcerative colitis, 29 with Crohn's disease in the colon, four with diverticular disease, and eight with sigmoid volvulus.
G, Frykholm   +3 more
openaire   +2 more sources

[Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].

Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma, 1986
CA 19-9, a new antigenic tumor marker for gastrointestinal tumors, has been assayed with Carcinoembriogenic antigen, in 90 healthy patients and 47 patients with gastric cancer (20) and colorectal cancer (27). A good specificity has been found for this antigen (97.7%). Its sensibility seems to be slightly superior to that of CEA. However the sensibility
E, Capocasale   +4 more
openaire   +1 more source

Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen

American Journal of Obstetrics and Gynecology, 1984
CA 125 and CA 19-9 are antigenic determinants associated with human epithelial ovarian carcinomas. Murine monoclonal antibodies have been raised against these determinants, and immunoradiometric assays have been developed to monitor antigen levels in the serum of cancer patients. This study was undertaken to determine whether concomitant measurement of
R C, Bast   +7 more
openaire   +2 more sources

Serum CA 19-9 and CA 50 antigens in hemodialysis patients.

Clinical nephrology, 1987
Serum concentrations of monoclonal antibody-defined tumor markers CA 19-9 and CA 50 were measured in 64 uncomplicated hemodialysis patients (Group 1) and in 8 hemodialysis patients with cancer (Group 2) in comparison with corresponding CEA determinations.
D, Docci   +5 more
openaire   +1 more source

[Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1993
Carbohydrate Antigen 19-9 (CA 19-9) histological expression in transitional cell bladder carcinoma (TCBC) was studied by means of immunohistochemistry and its findings compared with those of Tissue Polypeptidic Antigen (TPA) and Carcino Embryonic Antigen (CEA).
G, Casetta   +5 more
openaire   +1 more source

Serum levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 in patients with endometriosis

Journal of Endocrinological Investigation, 1988
The levels of the oncofetal antigens CA-125, CA 19-9 and CA 15-3 were measured in serum samples taken from 8 women, aged 21 to 37 yr, before treatment, during the last fifteen days of a 6-month administration of danazol and finally three months after treatment withdrawal.
D, Panidis   +4 more
openaire   +2 more sources

CA 19–9, GICA (Gastrointestinal Cancer Antigen)

1992
Following the detection and clinical exploitation of alphafetoprotein (AFP), calcinoembryonic antigen (CEA), and human chorionic genadotropin (HCG) as first and basic tumor markers, the discovery of blood group-related carbohydrate structures on glycoproteins and glycolipids as indicators of malignancy has opened a wide array of scientific and clinical
openaire   +1 more source

Vorkommen der tumorassoziierten Antigene CA 50 und CA 19-9 in Endometriumkarzinomen

Archives of Gynecology and Obstetrics, 1993
Das tumorassoziierte Antigen CA 19-9 entspricht dem sialysierten Lewisa Blutgrup- penantigen. Das Antigen CA 50 setzt sich aus diesem Epitop und einer weiteren Zuckergruppe zusammen. Serumbestimmungen von CA 19-9 und CA 50 eignen sich zur Verlaufskontrolle von Pankreas- und Dickdarmkarzinomen (Nakagoe et al.; Schwenk et al.).
U. -J. Göhring   +3 more
openaire   +1 more source

Serum CA 125, Carcinoembryonic Antigen, and CA 19-9 as Tumor Markers in Borderline Ovarian Tumors

Gynecologic Oncology, 2000
The goals of this study were to analyze preoperative serum levels of CA 125, carcinoembryonic antigen (CEA), and CA 19-9 in patients with borderline ovarian tumors and to investigate if routine assessment of these markers in follow-up may lead to earlier detection of recurrence.For patient identification a database was used, in which data from all ...
Engelen, MJA   +6 more
openaire   +3 more sources

[Tissue expression of carbohydrate antigen 19-9 (CA 19-9) in adenomatous lesions of the colorectum].

Chirurgia italiana, 1999
Serum levels of tumor markers almost not detectable in precancerous states or early cancer, the behavior of the tumor associated antigen CA 19-9 in colorectal carcinogenesis was analysed. In order to investigate the adenoma-carcinoma sequence, tissue antigenic expression was measured in adenomas, characterized by different size and histology, and ...
G F, Tucci   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy